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Summary
The action of antipsychotic drugs on dopamine recep-
tors suggests that dopaminergic signal transmission may
play a role in the development of schizophrenia. We
tested eight candidate genes (coding for dopamine re-
ceptors, the dopamine transporter, and G-proteins) in
59 families from Germany and Israel, for association. A
P value of .00055 (.0044 when corrected for the no. of
markers tested) was obtained for the intronic CA-repeat
marker G-olfa on chromosome 18p. The value decreased
to .000088 (.0007) when nine sibs with recurrent uni-
polar depressive disorder were included. Linkage anal-
ysis using SSLP markers densely spaced around G-olfa
yielded a maximum two-point LOD score of 3.1 for a
marker 0.5 cM distal to G-olfa. Multipoint analysis un-
der the assumption of heterogeneity supported this link-
age—whether the affected pheotype was defined nar-
rowly or broadly—as did nonparametric linkage (NPL).
In 12 families with exclusively maternal transmission of
the disease, the NPL value also supported linkage to this
marker. In order to test for association/linkage disequi-
librium in the presence of linkage, the sample was re-
stricted to independent offspring. When this sample was
combined with 65 additional simplex families (each of
them comprising one schizophrenic offspring and his or
her parents), the 124-bp allele of G-olfa was transmitted
47 times and was not transmitted 21 times ( ).P  .009
These results suggest the existence, on chromosome 18p,
of a potential susceptibility locus for functional psy-
choses.
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Introduction
Segregation analysis and epidemiological studies in
schizophrenia (Risch and Baron 1984; Baron 1986) as
well as in affective disorder (O’Rourke et al. 1983; Rice
et al. 1987) suggest that oligo- or polygenic inheritance
may be the most likely underlying mode of transmission
for these disorders. The pattern of recurrence risk as
reported in the literature is compatible with a small num-
ber of possibly interacting genes conferring susceptibility
for schizophrenia and/or affective disorder (Risch 1990).
Given the familial overlap between both syndromes, it
is conceivable that some of these genes may be common
to both types of functional psychoses and thus may con-
tribute to vulnerabilty in general whereas others may
specify the type.
On the basis of the pharmacological activity of anti-
psychotic and antidepressant drugs, schizophrenia has
been considered to be associated with altered dopami-
nergic transmission and affective disorders with a dis-
turbance of adrenergic or serotonergic transmission. In
the past, investigations of functional changes in these
neurotransmitter systems in the brain have dominated
the search for the molecular causes of psychiatric dis-
orders. Altered function of these neurotransmitters has
been demonstrated, by a variety of techniques, in some
but not all of the patients. However, the causes have not
been unraveled for either of these disorders. Using as-
sociation analysis and linkage analysis to investigate can-
didate genes and regions, which are selected on the basis
of a possible involvement in the pathophysiology of the
disease, should be one way to shed light on the etiology
of schizophrenia and/or affective disorders.
We have studied genes that are involved in the do-
paminergic pathway and that can be considered as can-
didate genes for the development of schizophrenia. The
dopamine receptors D1 (Cichon et al. 1996) D2 (Hall-
mayer et al. 1994; No¨then et al. 1994), D3 (No¨then et
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al. 1993), and D4 (Maier et al. 1994), the dopamine
transporter (Maier et al. 1996), and, in addition, the
genes for G-proteins, which may be coupled to these
receptors—namely, the G-protein subunit Gs a (gene
GNAS 1) and G-olfa (gene GNAL)—have been tested by
association analysis in 59 families, each of which was
ascertained through an index patient with schizophrenia
and had at least one affected sib pair. A statistically
significant transmission/disequilibrium test (TDT) was
obtained for the short sequence length polymorphism
(SSLP) marker G-olfa, which maps to chromosome 18p
(Ala-Kokko et al. 1995). It has been shown that G-olfa,
which was first identified in the olfactory epithelium, is
also highly expressed in caudate putamen and nucleus
and appears to be coupled to the dopamine D1 receptor
(Herve et al. 1993, 1995; Sakagami et al. 1995).
The TDT has been developed by Spielman et al. (1993)
to detect linkage in the presence of association/linkage
disequilibrium. Therefore, the initial finding was eval-
uated also by testing for linkage of G-olfa and a series
of SSLP markers in its neighborhood, by conventional
linkage analyses using parametric and nonparametric
methods. We obtained additional evidence for linkage
when both diagnoses—schizophrenia and affective dis-
order—were included in the analysis. This increase in
LOD-score value by addition of family members with
affective disorders is of particular interest, since evidence
for a susceptibility locus for bipolar disorder has been
reported, for the same region, by Berrettini et al. (1994),
a result partly replicated by Stine et al. (1995). Our
results provide evidence for the existence of genetic fac-
tors on chromosome 18p that confer susceptibility to
functional psychoses in families with schizophrenia.
Since other parts of chromosome 18 have been shown
to be possibly linked to affective disorders (Stine et al.
1995; De bruyn et al. 1996; Freimer et al. 1996), the
entirety of chromosome 18 was analyzed for evidence
of linkage. No evidence for additional susceptibility loci
was obtained in our sample of families with schizo-
phrenic index patient.
Subjects, Material, and Methods
Family Sample
A total of 59 families were collected, consisting of 30
nuclear families from Haar (Germany), 13 nuclear and
5 extended families from Mainz (Germany), and 7 nu-
clear and 4 extended families from Israel. Of the families
from Israel, nine were Jewish non-Ashkenazic, one was
Ashkenazic, and one was of Arabic origin. The families
recruited in Haar and Mainz were of German heritage.
Further details of the pedigree sample are listed in table
1. There were 124 individuals affected with schizophre-
nia, and there were 32 individuals affected with schizoaf-
fective disorder (on the basis of Research Diagnostic Cri-
teria [RDC]) constituting the core diagnosis. These
diagnoses were included in calculations using the nar-
rowly defined disease (“narrow” disease) model. In ad-
dition, the sample contained 23 individuals with recur-
rent unipolar depression, 1 individual with bipolar
disorder I, and 1 individual with bipolar disorder II.
These individuals were considered as affected, in anal-
yses considering a broadly defined disease (“broad” dis-
ease) model. The sample for linkage analysis also
included 18 individuals with minor depression, 4 indi-
viduals with personality disorder, and 11 individuals
with alcoholism. Since there is no epidemiological evi-
dence for cosegregation with schizophrenia in families,
these phenotypes were not included as affected, in the
disease models used in this analysis.
For investigation of sex-dependent effects in linkage
analysis, the families were subdivided according to the
pattern of transmission. Only families with unilineal in-
heritance were considered. The affection status was
schizophrenia, chronic schizoaffective disorder (RDC),
bipolar disorder, and recurrent unipolar disorder. Four
families in which inheritance was bilineal were excluded.
In 30 families the affection status of parents or ancestors
was not known to us, so that we could not determine
either maternal or paternal inheritance unambiguously.
The rest of the families were classified as being either
only maternally transmitted (12 families) or maternally
and paternally transmitted (13 families), according to
the suggestions of Gershon et al. (1996). For sex-de-
pendent transmission in linkage-disequilibrium analysis
of the marker alleles of G-olfa, the TDT was performed
only in families in which the parents differed in geno-
type, in order to determine unambiguously whether an
allele was transmitted from either the father or the
mother.
The sample of 65 simplex families (nuclear families
with one affected sib [i.e., triads]) with family history
was ascertained in the areas of Haar and Mainz, in order
to increase the sample size for association/linkage-dise-
quilibrium studies in the presence of linkage.
Cell Lines and Genomic DNA
Permanent cell lines were established from all indi-
viduals of all ascertained families by transformation of
lymphocytes by means of Epstein-Barr virus, by standard
techniques. Genomic DNA was prepared from either
whole blood or cell lines by means of a Quiagen blood-
and cell-culture DNA kit. The DNA was dissolved to a
concentration of 10 mg/ml, which was used as stock
solution.
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Table 1
Characteristics of the Family Sample
CATEGORY
NO. (NO. WITH AFFECTIVE DISORDERS) IN
Jerusalem Haar Mainz Total
All families: 11 30 18 59
Individuals 123 142 151 416
Affected 34 (40) 66 (78) 56 (66) 156 (184)
Affected/family 3.1 (3.6) 2.2 (2.6) 3.1 (3.6) 2.6 (3.1)
Nuclear families:
Both parents 6 28 12 46
One parent 2 1 1 4
Individuals 83 124 60 277
Affected 22 (25) 63 (74) 30 (31) 115 (130)
Affected/family 2.75 (3.1) 2.1 (2.5) 2.3 (2.4) 2.3 (2.6)
Extended families:
Twoa/three generations 0/3 1/0 1/4 2/7
Individuals 40 8 91 139
Affected 12 (15) 3 (4) 26 (35) 41 (54)
Affected/family 4.0 (5.0) 3.0 (4.0) 5.2 (7.0) 4.6 (5.7)
Siblings:
Pairs 7 (4) 28 (26) 17b (20) 52 (50)
Triplets 1 (4) 2 (4) 2 (2) 5 (10)
Quadruplets 2 (2) 0 (0) 0 (0) 2 (2)
Quintuplets 1 (0) 0 (0) 0 (0) 1 (0)
Sextuplets 0 (1) 0 (0) 0 (0) 0 (1)
Sib-pair totals:
( ) pairsk 1 19 (23) 32 (34) 21 (24) 72 (81)
pairs1k(k 1)2 32 (43) 34 (38) 23 (26) 89 (107)
a Two generations include second-degree relatives.
b Two affected sib pairs are in different branches.
Markers
The following markers were from the Ge´ne´thon map
(Dib et al. 1996): D18S464, D18S1158, D18S1116,
D18S53, D18S73, D18S453, D18S71, D18S1114,
D18S478, D18S469, D18S57, D18S64, D18S61,
D18S56, D18S59, and D18S68. Other markers included
G-olfa (Ala-Kokko; also see Genome Database [acces-
sion number GDB 196597]); D18S37 and D18S40
(Straub et al. 1993); and D18S852, D18S975, and
D18S866 (Cooperative Human Linkage Center).
The order of the map for multipoint linkage was based
on data form Giacalone et al. (1996), Esterling et al.
(1997), and the Genetic Location Database map. Dis-
tances were taken from the literature as described in the
Genome Database and, in the case of the family sample
in the present study, also were calculated by GENE-
HUNTER. Marker-allele frequencies and heterozygosity
were determined on the basis of genotypes of 110 un-
related individuals taken from the family sample.
Family Ascertainment
Families with index-patient with either schizophrenia
or chronic schizoaffective disorder (mainly schizo-
phrenic, on the basis of RDC; Spitzer et al. 1978) were
ascertained consecutively at the State Mental Hospital
at Haar (which is located in the area of Munich), under
the supervision of M.A., and at the Psychiatric Hospital
of the University of Mainz, under the supervision of
W.M. Families from Israel were referred, from several
Psychiatric Hospitals in Israel, to the Hadassah Medical
School of the University of Jerusalem and were ascer-
tained under the supervision of B.L.
The ascertainment plan for multiplex families was de-
signed mainly for affected-sib-pair analysis using the
core phenotype schizophrenia/chronic schizoaffective
disorder. Therefore, families with aggregation of bipolar
disorder—that is, families with either sibs with bipolar
disorder, in addition to the schizophrenic individual, or
with more than one relative with bipolar disorder—were
excluded. No ascertainment restriction with regard to
the unipolar depressive phenotype (recurrent) was
applied.
The following types of families were ascertained ac-
cording to the aforementioned procedure:
Nuclear families with two and more affected sibs: The
minimum requirement for inclusion of a family within
the sample for linkage studies was the availability of two
affected sibs both affected with either schizophrenia or
chronic schizoaffective disorder, together with both par-
ents, independent of the latters’ psychiatric diagnosis (for
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identity-by-descent analysis). Additional, unaffected sibs
were recruited for genotyping when only one parent was
available; this was the case for four families.
Extended families: A nuclear family was extended to
other branches when first- and second-degree relatives
affected with either schizophrenia or chronic schizoaf-
fective disorder were available for interview, diagnosis,
and blood sampling.
Simplex families (i.e., triads): Families with one in-
dividual affected with schizophrenia or schizoaffective
disorder and with both parents available for both eval-
uation and blood sampling were ascertained when fam-
ily history revealed the presence of at least one additional
family member affected with either schizophrenia or bi-
polar or recurrent unipolar disorder.
Clinical Evaluation
The study has been approved by the local ethics com-
mittees, and written informed consent was obtained
from all participants after they had received a description
and explanation of the study. Probands and relatives
were interviewed by means of the Schedule for Affective
Disorders and Schizophrenia–Lifetime version (Fyer et
al. 1985) and the Structured Clinical Interview for DSM-
III Diagnoses–Personality Disorders (Spitzer and Wil-
liams 1985). In addition, the relatives of the proband
were asked about the presence of psychiatric symptoms
in the family, by means of the family-history research
criteria. Lifetime diagnoses based on RDC (Spitzer et al.
1978) were obtained by the best-estimate diagnosis pro-
cedure (Leckman et al. 1982). Case records were eval-
uated by means of the Operational Criteria Checklist
(McGuffin et al. 1991). The completed interview form,
the family-history information, and the medical records
of an individual were reviewed by an experienced psy-
chiatrist, who was blinded both to the individual’s fa-
milial relationship to the index case and to morbidity in
the family. When a definite diagnosis could not be made,
additional information was collected by reinterviewing
of either the proband or other family members.
Genotypings
Amplification of marker loci was done by PCR either
with 32P–end-labeled oligonucleotides, for detection of
radioactivity, or with fluorescence-labeled primers, for
fragment analysis by means of an ABI sequencer type
377. PCR was performed in a 10-ml volume containing
50 ng of genomic DNA; 200 mM each of dATP, dGTP,
dCTP, and dTTP; 2 pmol of each primer (for detection
of radioactivity, the reverse primer had been 5′–end la-
beled by T4 polynucleotide kinase and g-[32P-]ATP); 50
mM KCl; 10 mM Tris-HCl (pH 8.3); 1.5 mM MgCl2;
and 1.25 U of Taq polymerase (Pharmacia). The samples
were processed either in a Perkin-Elmer Thermo Cycler
9600 or in an MJ Research PTC-200 Peltier thermal
cycler, by means of microtiter plates. An initial dena-
turation period of 4 min at 95C was followed by 30
cycles each of 20 s at 95C, 20 s at 55C, and 30 s at
72C. A final synthesis step, consisting of 10 min at
72C, was added. In the case of the radioactively labeled
product, 20 ml formamide tracking dye was added, the
samples were heated for 5 min at 95C, and 4 ml of each
sample was loaded onto a sequencing gel containing 6%
acrylamide and 8 M urea. Labeled products were de-
tected by autoradiography overnight, by means of Ko-
dak X-omat XAR. Autoradiograms were scored by two
investigators independently, who were blinded to phe-
notype, and the alleles were assigned to the pedigree
members. Fluorescence-based technology was used for
markers D18S59, D18S56, D18S57, D18S64, D18S68,
D18S61, and D18S469. After completion of PCR
reactions, samples containing amplification products
labeled with either 4,7,2′,7′-tetrachloro-6-carboxy-
fluorescein (TET), 6-carboxyfluorescein (6-FAM), or
4,7,2′,4′,5′,7′-hexachloro-6-carboxyfluorescein (HEX),
distilled water was added, to give a dilution of either 1:
10, for HEX-labeled products, 1:20, for 6-FAM–labeled
products, or 1:40, for TET-labeled products. To 1.5 ml
of this dilution, 0.2 ml of GS 500 Tamra (ABI), 0.2 ml
of loading buffer (ABI), and 1.6 ml of formamide were
added. The samples were denatured, and 2 ml of each
was loaded on a 6% denaturing polyacrylamide gel in
the electrophoresis unit of the sequencer. Genotyping
software GeneScan 2.0.2 and Genotyper 1.1 (ABI) were
used for data collection and evaluation. Allele sizes were
determined on the basis of analysis of representative
samples by fluorescence technology and the molecular-
weight marker GeneScan-500-TAMRA directly supplied
by ABI.
Statistical Analysis
The following two definitions of the affected pheno-
type were used for calculations:
1. Narrow disease model: schizophrenia and schizof-
fective disorder, mainly schizophrenic;
2. Broad disease model: in addition to schizophrenia
and schizoaffective disorder, as in the narrow dis-
ease model, recurrent unipolar and bipolar disorders I
and II.
In both models, the index patient and at least one sib
had a diagnosis of either schizophrenia or schizoaffective
disorder (mainly schizophrenia).
Two-point LOD-score values were calculated by
FASTLINK (Cottingham et al. 1993; Scha¨ffer et al.
1994) version 3 of MLINK of the program package
LINKAGE (Lathrop and Lalouel 1984). This analysis
was performed, with markers D18S464, D18S1158,
D18S53, D18S1116, D18S71, D18S453, D18S37,
Schwab et al.: Chromosome 18 and Schizophrenia 1143
Table 2
Transmission of G-olfa-Associated Marker Alleles to All Affected
Sibs
ALLELE SIZE [IN BP]
(FREQUENCY)
AND MODEL
NO.
TDT (P)aTransmitted Nontransmitted
106 (.07):
Narrow 15 15 .00
Broad 15 16 .032
112 (.10):
Narrow 29 21 1.28
Broad 30 24 .9
114 (.155):
Narrow 28 44 3.55
Broad 29 47 4.26
116 (.40):
Narrow 48 77 6.73
Broad 52 79 5.56
118 (.015):
Narrow 5 3 .5
Broad 6 3 1.09
120 (.015):
Narrow 11 4 3.26
Broad 11 5 2.25
122 (.03):
Narrow 4 6 .4
Broad 4 6 .49
124 (.175):
Narrow 41 13 14.52 (.0007)
Broad 45 13 17.65 (.00012)
a Data are TDT-like likelihood-ratio statistics based on an algorithm
of Terwilliger (1995); P values are multiple-test corrected. For the
narrow model, the maximum-likelihood estimate of TDT is 10.654
( ); for the broad model, the maximum-likelihood estimateP  .00055
of TDT is 14.077 ( ).P  .000088
D18S852, D18S1114, D18S40, D18S866, D18S478,
and D18S975, for the whole family set, which included,
in addition to the sibs, all other available relatives. A
dominant model was used for linkage analysis. A pen-
etrance of .55, a phenocopy rate of .001, and a disease-
allele frequency of .02 were used with the narrow disease
model. Two-point LOD-score values for the broad dis-
ease model were calculated with a penetrance of .77, a
phenocopy rate of .05, and a disease-allele frequency of
.06. These values are adopted from Su et al. (1993).
Multipoint analysis was performed by GENE-
HUNTER (Kruglyak et al. 1996). Because of time and
memory constraints in the performance of multipoint
analysis, the larger families were divided into smaller
subfamilies. Sib-pair analysis was performed on the basis
of identity by descent (Penrose 1953; Suarez and Van
Eerdewegh 1984). The alleles transmitted from one in-
formative parent to a pair of affected sibs were scored
and counted as either shared or not shared. The mean
test was used for calculation of P values (Knapp et al.
1994a, 1994b).
The TDTLIKE - Alpha Test Version for computation
of TDT-like likelihood-ratio statistics, based on an al-
gorithm of Terwilliger (1995), was used for calculation
of transmissions of G-olfa marker alleles to affected sibs,
by TDT (Spielman et al. 1993). However, meioses are
not independent among affected sibs if linkage has been
detected (Spielman and Ewens 1996). Therefore, in the
testing for linkage disequilibrium, a heterozygous parent
in a family with two affected sibs was either discarded
from the analysis, if this parent transmitted different
alleles to both sibs, or was counted as a single obser-
vation, if this parent transmitted the same allele to both
sibs (Martin et al. 1997). In a family with more than
two affected sibs, this procedure was applied with two
randomly chosen affected sibs from the family. With
these data, a TDT statistic was calculated for each G-
olfa allele, by consideration of all other alleles as a single
allele. The maximum of these TDT statistics was used
in the testing for linkage disequilibrium. A randomiza-
tion technique (with permutations) as de-R  20,000
scribed by Morris et al. (1997) was employed to obtain
P values corresponding to the observed maximum of
TDT statistics.
Results
Evidence for Transmission Disequilibrium of G-olfa
Marker Alleles
While testing eight candidate genes for psychiatric dis-
orders (i.e., the dopamine receptors D1–D5, the dopa-
mine transporter, and the G-proteins Gsa and G-olfa),
we obtained, in a sample of 59 families with affected
sib pairs, for the intronic dinucleotide-re-P  .00055
peat marker G-olfa, by the TDT (see table 2). The P
value remained significant when Bonferroni correction
for the number of used markers was applied (P 
). When the disease definition was extended to in-.0044
clude unipolar and bipolar disorder, the value decreased
to .000088 (corrected ). The 124-bp allele ofP  .0007
the CA repeat was transmitted more often than would
be expected by chance (narrow disease definition, P 
; broad disease definition, ). Since the.0007 P  .00012
TDT simultaneously tests for association and linkage,
we evaluated the finding further by applying parametric
and nonparametric LOD-score methods to test for
linkage.
Evidence for Linkage to Chromosome 18p, by
Parametric and Nonparametric Methods
Classic two-point LOD-score analysis was performed
for the marker G-olfa and revealed LOD-score values of
2.07 (recombination fraction [v] .15), for the narrow
disease definition, and 1.76 ( ), for the broad dis-v  .2
ease definition, in the total family sample (table 3). Sub-
sequently, the region around the locus for G-olfa was
saturated with 13 additional SSLP markers (fig. 1).
For these analyses, we included the more distantly
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Figure 1 Diagram of chromosome 18 with markers used in link-
age studies (ideogram is from Bray-Ward et al. 1996). Distances are
from Genome Database.
Table 3
Marker Characteristics, Two-Point LOD Scores, and Allele Sharing
MARKER HETEROZYGOSITYa
ALLELE SHARINGc
DISTANCE
(cM) TWO-POINT Zmax (v)
b Narrow Broad
Previously
Published
Present
Studyd Narrow Broad Shared
Not
Shared P Shared
Not
Shared P
D18S59 (A) 34.3 36 .831 .08 (.35) .18 (.3) 51 54 51 54
D18S464 (B) 5.7 6 .540 ) ) 23 24 26 29
D18S1158 (C) .6 1 .650 .33 (.25) .32 (.3) 53 44 59 48
D18S1116 (D) .5 0 .630 1.98 (.1) 1.98 (.15) 60 40 (.045) 72 39 (.0017)
D18S53 (E) .5 0 .796 1.76 (.15) 3.1 (.15) 88 59 (.017) 103 64 (.0025)
GOLF (F) .8 1 .764 2.07 (.15) 1.76 (.2) 80 56 (.04) 94 61 (.008)
D18S71 (G) .6 1 .850 1.23 (.2) 2.16 (.2) 88 65 96 67 (.023)
D18S37 (H) .6 1 .590 1.3 (.15) 1.64 (.2) 58 45 73 52 (.06)
D18S40 (I) .2 1 .840 .81 (.25) 2.07 (.2) 85 73 100 80
D18S852 (J) .5 2 .450 .27 (.2) .52 (.2) 31 26 35 29
D18S114 (K) .4 0 .780 .74 (.25) 1.73 (.25) 72 64 83 69
D18S453 (L) 5.6 5 .825 .48 (.25) .86 (.25) 71 67 84 72
D18S975 (M) .7 3 .684 .81 (.25) 2.17 (.2) 61 57 74 60
D18S866 (N) 1.7 3 .652 ) .11 (.25) 52 48 64 54
D18S478 (O) 2.9 4 .600 ) .75 (.25) 44 32 49 43
D18S56 (P) 4.1 7 .759 ) ) 51 53 51 53
D18S57 (Q) 24.6 23 .832 .23 (.25) .09 (.3) 42 38 42 38
D18S64 (R) 12.7 14 .760 .25 (.25) ) 67 59 67 59
D18S68 (S) 6.9 8 .821 ) ) 54 57 54 57
D18S61 (T) 6.4 7 .853 .84 (.25) .04 (.35) 73 56 73 59
D18S469 (U) .681 ) ) 59 47 59 47
a Calculated in 110 individuals.
b An ellipsis ()) denotes that there were negative two-point LOD scores for all values of v tested.
c Identical by descent, for all possible sib-pair combinations.
d Distances were calculated by GENEHUNTER.
related relatives suffering from schizophrenia and schi-
zoaffective disorder and, for the broad disease model,
also the relatives with affective disorders (table 1). Sev-
eral markers revealed positive LOD-score values (table
3). A maximum LOD score (Zmax) of 3.1 was obtained
with marker D18S53, at , for the broad diseasev  .15
model. D18S53 is 0.5 cM distal to G-olfa (table 3). There
was also evidence for linkage by nonparametric sib-pair
analysis (table 3). The highest value, with 72 shared
versus 39 nonshared ( ), was observed forP  .0017
marker D18S1116, which is 0.5 cM distal to D18S53
and ∼1 cM distal to G-olfa.
Multipoint Analysis
Recent findings in bipolar disorder (Berrettini et al.
1994; Stine et al. 1995; Freimer et al. 1996; McMahon
et al. 1997) suggest, in addition, that susceptibility loci
for bipolar disorders are on the long arm of chromosome
18. Therefore, additional markers, spanning the entire
chromosome, were included for multipoint analysis (fig.
1). Multipoint linkage analysis was performed by the
program GENEHUNTER (Kruglyak et al. 1996). The
marker distances used in this analysis were taken from
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Figure 2 HLOD values (marker designations and distances are as in fig. 1). For the broad disease definition (upper curve, with blackened
circles), , ; for the narrow disease definition (lower curve, with unblackened circles), , .Z  2.92 a  .36 Z  1.59 a  .37max max
the literature. In the family sample used in the present
study, we also calculated marker distances by GENE-
HUNTER. In some cases, the distances were larger,
probably because of the composition of our family sam-
ple, which differs from that of the CEPH families used
for construction of the published maps. Since these
differences could be due to typing errors, we formed
haplotypes by using all markers and checked all recom-
binants by retyping. LOD-score analysis assuming
heterogeneity (HLOD) reached a maximum value
around marker D18S53—1.6 (37% of the families
linked) for the narrow disease model and 2.92 (36% of
the families linked) for the broad disease model. No
additional peak was seen with markers on 18q (fig. 2).
Nonparametric analysis with GENEHUNTER (fig. 3)
revealed a maximum NPL (NPLmax) around marker
D18S53—2.41 ( ) for the narrow disease modelP  .008
and 2.9 ( ) for the broad disease model. ThereP  .0023
was a small additional peak toward the end of the long
arm (around marker D18S61), but this peak did not
reach a statistically significant value ( ,NPL  1.3 P 
)..097
Parent-of-Origin Effect
A parent-of-origin effect has been described in trans-
mission of bipolar disorders (Stine et al. 1995; Gershon
et al. 1996). To test for the effect in our sample with
families with schizophrenia, we divided the sample into
two categories—families transmitting the disease exclu-
sively maternally (12 families) and families transmitting
the disease paternally and maternally (13 families), as
described above in the Family Sample subsection. NPL
was calculated by GENEHUNTER. In contrast to the
results from study of bipolar disorder, no evidence for
linkage in paternally and maternally transmitting fam-
ilies was detectable in our sample (fig. 4). However, as
shown in figure 4, an NPLmax of 2.83 ( ) aroundP  .0022
the locus for G-olfa was obtained when the 12 exclu-
sively maternally transmitting families were analyzed.
The TDT as a Test for Association/Linkage
Disequilibrium in the Presence of Linkage
As discussed by Spielman and Ewens (1996), the TDT
is not valid as a test of association in multiplex families
when linkage has been detected. If linkage is present,
meioses cannot be considered as independent in affected
sibs.
Therefore, the family sample was restricted to those
heterozygous parents, of affected sib pairs, who trans-
mitted the same allele to both sibs (Martin et al. 1997).
The frequency difference between transmission and non-
transmission of the 124-bp allele was statistically sig-
nificant ( ; see table 4), but the number of ob-P  .0043
servations after application of this procedure was low.
Therefore, we expanded the sample by including 65 sim-
plex families (triads) that had been ascertained, for fam-
ily-based association studies, in Haar and Mainz. The
124-bp G-olfa marker allele, which, in the general
1146 Am. J. Hum. Genet. 63:1139–1152, 1998
Figure 3 Nonparametric LOD values (marker designations and distances are as in fig. 1). For the broad disease definition (upper curve,
with blackened circles), , ; for the narrow disease definition (lower curve, with unblackened circles), ,NPL  2.9 P  .0023 NPL  2.40max max
.P  .0083
population, has a frequency of 17% (Ala-Kokko et al.
1995), was transmitted 33 times and was not transmitted
19 but failed to reach statistical significance (table 4).
When both samples were analyzed together, the 124-bp
allele was transmitted 47 times and was not transmitted
21 times. When the method of Morris et al. (1997) was
used for correction, this result was statistically significant
( ; table 4). The 124-bp allele was observed toP  .0091
be more frequently transmitted from the mother than
from the father (table 4). Maternal transmission was
statistical significant in the expanded family sample
( ; table 4).P  .0192
Discussion
The present study provides suggestive evidence, from
both association/linkage disequilibrium studies and link-
age studies, for a locus, on chromosome 18p, that may
confer susceptibility to functional psychoses in families
with schizophrenic index patients who have been ascer-
tained for linkage studies in schizophrenia. Functional
psychoses were first differentiated at the beginning of
the century, by Emil Kraepelin (1899), into manic-de-
pressive insanity (bipolar disorder) and dementia precox
(schizophrenia). This classification was based on both
the outcome of the disease and the presence of prominent
mood symptoms in manic-depressive insanity. The con-
cept has been very helpful in the development of diag-
nosis and therapy for these disorders but has been ques-
tioned in studies on symptomatology and genetic
transmission (Taylor 1992; Maier et al. 1993):
1. Intermediate forms such as schizoaffective disorders
occur in families with both disorders (Kendell and Gour-
lay 1970; Taylor and Amir 1994).
2. Family studies have revealed co-occurence of
schizophrenia and affective disorder in some families
(Gershon et al. 1988; Taylor 1992; Maier et al. 1993)
but not in others. An increased risk for affective disor-
ders among first-degree relatives of schizophrenia has
been described (Gershon et al. 1988).
3. Presence of affective disorders predisposes to
schizophrenia in later generations (Coryell et al. 1985).
These observations raise the possibility of familial or
genetic factors that may be shared by both disorders.
Consequently, a continuum of liability has been sug-
gested for the functional psychoses (Crow 1986).
Evidence for a locus that may predispose to the de-
velopment of functional psychoses is based on the fol-
lowing observations:
1. A preferential transmission of the 124-bp G-olfa
marker allele to sibs affected with schizophrenia and
schizoaffective disorders is detected by TDT (table 2),
suggesting association/linkage disequilibrium. The value
increases when sibs with unipolar and bipolar disorder
are included.
2. LOD-score analyses using parametric and nonpar-
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Table 4
Transmission of 124-bp G-olfa Marker Allele in Families,
in a Sample of 65 Simplex Families (Triads), and in
Combined Samples
SAMPLE AND
TRANSMISSION
NO.
PaTransmitted Nontransmitted
Families:
Paternal 5 1 )
Maternal 7 1 .0523
Combined 14 2 .0043
Triads:
Paternal 8 10 )
Maternal 17 7 )
Combined 33 19 .2531
All:
Paternal 13 11 )
Maternal 24 8 .0193
Combined 47 21 .0091
NOTE.—Paternal/maternal transmission was determined
only in parents with different genotypes.
a Corrected by the randomization technique of Morris
et al. (1997).
Figure 4 Nonparametric LOD values for parent-of-origin families (marker designations and distances are as in fig. 1). For the upper
curve, which represents data for 12 maternal families, , ; for the lower curve, which represents data for 13 paternal/NPL  2.83 P  .0022max
maternal families, , .NPL  1.1 P  .13max
ametric methods provide support for linkage, in the
chromosomal region of 18p, centered around the mark-
ers D18S1116/D18S53/G-olfa (table 3 and figs. 2–4).
3. LOD scores increase when a broad disease model,
which includes recurrent unipolar (23 individuals) and
bipolar (2 individuals) illness, is used for analysis (table
3 and figs. 2 and 3) An increase of LOD scores in our
pedigree sample by a broadening of the phenotype has
not been observed for the potential susceptibility loci,
on chromosome 6 (Schwab et al. 1995) and 5 (Schwab
et al. 1997), recently published by our group.
4. Evidence of linkage of bipolar disorder to chro-
mosome 18 has been reported by several groups (Ber-
rettini et al. 1994, 1997; Stine et al. 1995; Coon et al.
1996; De bruyn et al. 1996; Freimer et al. 1996; Mc-
Mahon et al. 1997).
5. Allele sharing for marker D18S53 ( ) in sibP  .02
pairs affected with schizophrenia has been reported by
DeLisi et al. (1995).
The hypothesis for study of marker G-olfa on chro-
mosome 18p was based on the possible involvement of
G-proteins in the etiology of schizophrenia. Our study
was, a priori, not designed to test the previously reported
linkage, for bipolar disorders, in the pericentromeric re-
gion of chromosome 18 in families with schizophrenia,
nor was its purpose to test the nosological distinction
between bipolar disorder and schizophrenia. However,
when we obtained, by TDT, evidence of association of
the SSLP marker G-olfa, we took into consideration the
findings in bipolar disorders and scanned the entirety of
chromosome 18, for the possible existence of additional
susceptibility loci, by multipoint linkage analysis.
Recent findings in linkage studies of bipolar disorders
support the view that we have obtained evidence for a
susceptibility gene, which may be common to both dis-
orders. Berrettini et al. (1994) have reported evidence,
in the pericentromeric region of chromosome 18, of a
gene for manic-depressive illness. With 11 markers and
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evaluation by parametric and nonparametric methods,
two positive areas were detected, one around D18S53
on 18p, an area identical to the region with the Zmax in
our sample, and another one around D18S56 on 18q.
Stine et al. (1995) have studied 28 nuclear families trans-
mitting the bipolar-affective-disorder phenotype, for
linkage with markers on chromosome 18. Affected-sib-
pair analysis revealed the greatest allele sharing for
marker D18S37, which is 1.9 cM proximal to D18S53
and which also shows excess allele sharing in our sample.
Stine et al. obtained additional evidence for a parent-of-
origin effect. The strongest evidence for linkage was ob-
served for two loci—one around D18S35 on 18p and
another around D18S41 on 18q—when pedigrees with
paternal transmission were identified and analyzed. Fur-
ther support for linkage to 18q, but not to other regions
on chromosome 18, was obtained in a sample of 30
additional pedigrees studied by McMahon et al. (1997),
supporting linkage to 18q, linkage that previously had
been reported by Stine et al. (1995). Supportive evidence
for a locus on 18q has been also published by Coon et
al. (1996) and De bruyn et al. (1996).
It also should be mentioned that several groups have
failed to replicate linkage between bipolar disorders and
chromosome 18 markers (Kelsoe et al. 1995; Maier et
al. 1995; Pauls et al. 1995; Smyth et al. 1995; LaBuda
et al. 1996; Detera-Wadleigh et al. 1997). Failure of
replication in complex disorders may be due to sample
size, which may be too small to have adequate power
for replication (Suarez 1994), but it also may be due to
other factors confounding linkage analyses in complex
disorder—for example, heterogeneity, small relative risk,
high allele frequencies, etc. In contrast to Berrettini et
al. (1994 ), Stine et al. (1995), and McInnes et al. (1996),
we observed, in our pedigrees with schizophrenic index
patients, positive LOD scores only for markers in one
area (D18S53/D18S37).
Another possible chromosome 18 susceptibility locus
for bipolar disorders has been reported by Freimer et al.
(1996), who analyzed markers in the telomeric region
18q22-qter, in a study of linkage disequilibrium in fam-
ilies of Costa Rican origin. We have included the mark-
ers—D18S64, D18S68, D18S61, and D18S469—from
the region that was positive in these Costa Rican fam-
ilies, in scanning the long arm of chromosome 18. There
was no evidence for an additional locus in this region,
but the data are not sufficient to exclude an additional
locus in our sample. There is also no support for this
locus in the bipolar-disorder–pedigree samples reported
by Berrettini et al. (1994, 1997).
If there is more than one locus on chromosome 18,
as data from studies on bipolar-disorder families suggest,
our results, which have been obtained in families with
schizophrenia, favor a locus around D18S53/G-olfa as
contributing to the development of the illness. To our
knowledge, there is only one report that has been pub-
lished on linkage analysis of chromosome 18 markers
in schizophrenic families (DeLisi et al. 1995). That study
reported a failure to find chromosome 18 pericentric
linkage in 32 families. However, the meaning of the re-
ported P value of .023 for marker D18S53, a marker
for which we obtained a two-point LOD score of 3.1
(table 3), may have to be reconsidered in the context of
our findings.
In the present study, a positive TDT was obtained for
marker G-olfa in the analysis of a sample of families
with affected sibs. The TDT (Spielman et al. 1993) ex-
amines transmission of alleles of a polymorphic locus
from heterozygous parents to an affected offspring, but
it can be applied to more than one affected sib if parents
are available for genotyping. This has been done in the
present study. However, in this case, the TDT is not valid
as a test for linkage disequilibrium when linkage is pres-
ent (Spielman and Ewens 1996), since, in the case of
linkage, the sibs cannot be considered as independent,
which is a requirement for application of the x2 test.
One method that could be used to overcome this prob-
lem would be to reduce the size of the sibships, to a
simplex family with only one affected offspring, by se-
lecting one sib randomly from each sibship. A more pow-
erful method has been proposed recently by Martin et
al. (1997), which has been applied in the present study.
The TDT results in the family sample were further
analyzed by investigation of an additional sample of 65
simplex families (i.e., triads). The failure to reach sta-
tistical significance may be due to the smaller sample
size, heterogeneity, differences in etiology, or other fac-
tors confounding genetic analysis of complex disorders.
However, a similar tendency was noticed, in that the
124-bp allele was transmitted more often to the affected
offspring than to the unaffected offspring (33 cases vs.
19 cases).
Besides supporting linkage results, linkage disequilib-
rium may be useful in the definition of the region for
physical mapping and gene identification and charac-
terization. This should be particularly helpful in the case
of polygenic disorders, in which a large number of fam-
ilies would be needed in order to narrow the region
(Lander and Schork 1994).
Linkage disequilibrium is usually detected in isolates
with founder populations, but, since it may persist for
as many as 100 generations (Jorde 1995), it also may
exist in populations in which the disease mutation can-
not be traced to a common founder. Most of the families
transmitting the 124-bp G-olfa marker allele were from
the southern part of Germany (the areas of Mainz and
Munich), but there also were three families from Israel
(one Ashkenazic, one non-Ashkenazic from Iraq, and
one non-Ashkenazic from Morocco) that transmitted the
allele. As Copeman et al. (1995) have shown for type 1
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diabetes mellitus and markers on chromosome 2q, link-
age disequilibrium may also be detected in mixed
populations.
Our TDT results are also supported by the results of
Tsiouris et al. (1996). While studying linkage disequi-
librium of G-olfa in families that were of northern Eur-
opean ancestry and had bipolar disorders, these authors
observed a transmitted:nontransmitted ratio of 22:14 for
the 124-bp allele. Although the P value is not significant,
the 124-bp allele revealed the lowest P value in the like-
lihood analysis.
Several groups have reported, for chromosome 18, a
parent-of-origin effect in bipolar disorder, resulting in
linkage in families with either paternal- (Stine et al.
1995) or paternal and maternal (Gershon et al. 1996)
transmission of the disease alleles. This was not seen in
our sample with schizophrenic index patients when it
was divided into maternally transmitting and paternally
and maternally transmitting families. In contrast to the
previous studies, we observed evidence for linkage in the
12 exclusively maternally transmitting families (fig. 4).
However, we cannot rule out the possibility that a chance
enrichment of linked families occurred when the sample
size was reduced. On the other hand, as shown in table
4, TDT analysis provides some further evidence for pref-
erential maternal transmission. In the family sample as
well as in the expanded sample, we observed a prefer-
ential maternal transmission of the 124-bp marker allele
of G-olfa, which reached statistical significance in the
combined sample (table 4).
Gender differences in prevalence, age at onset, symp-
toms, course, and outcome of schizophrenia and in psy-
chopathology are well known (Castle et al. 1995). These
differences may not necessarily be caused by genetic fac-
tors; rather, they may be caused by gene# environment
interactions and confounding factors such as ascertain-
ment bias, artifacts in diagnosis, and reduced reproduc-
tive fitness, which may be different between affected
males and females. On the other hand, maternal trans-
mission and imprinting have been suggested, for schizo-
phrenia, by Yaw et al. (1996), although they have not
been detected by others (Asherson et al. 1994). A pref-
erential maternal transmission in families with a schizo-
phrenic index patient would suggest that a paternally
imprinted locus in 18p is responsible for expression of
the phenotype in schizophrenia, whereas the reverse may
be seen in bipolar disorder. Thus, in analogy with the
Prader-Willi/Angelman syndromes, it may be speculated
that a differentially imprinted locus on chromosome 18
is responsible for the development of either schizophre-
nia or bipolar illness.
G-proteins are involved in transmembrane signaling
and are coupled to neurotransmitter receptors, which
may be involved in the etiology of schizophrenia. There-
fore, G-olfa, encoding the stimulatory subunit of a G-
protein can be considered as a candidate for a gene con-
ferring susceptibility to schizophrenia. A preliminary
examination of G-olfa exons by SSCP analysis did not
reveal mutations that might affect structure or function
of the protein. Other candidate genes in the region in-
clude IMP (Yoshikawa et al. 1997) and a gene for an
adrenocorticotropic-hormone receptor (Detera-Wad-
leigh et al. 1995).
If the positive TDT for G-olfa indicates linkage dise-
quilibrium with a susceptibility gene, the linked region
can be narrowed to an area of 1 cM. This should be a
good starting point for identification of additional can-
didate genes, which can be screened for disease-causing
mutations.
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